Enhance your nephrology practice with CME and tools focused on kidney medicine.
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
June 05, 2026
Glasgow
Advancing Patient-Centered, Guideline-Driven Management of Hyperkalemia in Adults With CKD and Associated Comorbidities
June 04, 2026
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Quantifying CKD-aP: Tools for Better Care
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Leonie Kraft, MD
Lucio Manenti, MD, PhD
Elevating CKD-aP Care: New Frontier
Translating Evidence Into Practice: Patient-Centered, Guideline-Driven Care in ANCA-Associated Vasculitis
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Is CKD-aP Hiding in Your Dialysis Center?
Improving Sleep and Mental Health in Patients with CKD-aP
The Patient-Clinician Connection in Managing CKD-aP
CKD-aP or Something Else? Decoding the Diagnosis
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Patrick Rossignol, MD, PhD
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Future Directions in Managing Hyperkalemia in CKD and HF
Potassium Binders in Practice: Clinical Trial Evidence
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.